(Q35085350)

6 August 2017

1 reference

title

B19 virus infection in renal transplant recipients (English)

1 reference

6 August 2017

Rossana Cavallo

1

1 reference

6 August 2017

C Merlino

2

1 reference

6 August 2017

D Re

3

1 reference

6 August 2017

C Bollero

4

1 reference

6 August 2017

M Bergallo

5

1 reference

6 August 2017

D Lembo

6

1 reference

6 August 2017

T Musso

7

1 reference

6 August 2017

G Leonardi

8

1 reference

6 August 2017

G P Segoloni

9

1 reference

6 August 2017

A Negro Ponzi

10

1 reference

6 August 2017

publication date

1 April 2003

1 reference

Journal of Clinical Virology

6 August 2017

published in

1 reference

6 August 2017

volume

26

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

361-368

1 reference

A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Human parvovirus B19 and pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Human parvovirus, the cause of erythema infectiosum (fifth disease)?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Experimental parvoviral infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Erythrocyte P antigen: cellular receptor for B19 parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus-like particles in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Persistent parvovirus B19 infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus associated aplastic crisis in homozygous sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Increase in B19 Viral Load Prior to Relapse of Anaemia in an AIDS Patient with Persistent B19 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Detection of human parvovirus B19 DNA by using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Chronic bone marrow failure due to persistent B19 parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Human parvovirus B19 infection in organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus B19 Clearance from Peripheral Blood after Acute Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus infection after renal transplant.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus B19 infection in pediatric transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Evaluation of commercial enzyme linked immunosorbent assay for detection of B19 parvovirus IgM and IgG

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus infections and hypoplastic crisis in sickle-cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Impact of cytomegalovirus infection on organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Infectious disease complications of renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Rapid detection of human parvovirus B19 DNA by dot-hybridization and the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus B19-associated red blood cell aplasia in combined immunodeficiency with normal immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Human parvovirus-associated red cell aplasia in the absence of underlying hemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

HUMAN PARVOVIRUS ARTHROPATHY

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Detection of human parvovirus B19 DNA by nested polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Large-scale screening for human parvovirus B19 DNA in clinical specimens by dot blot hybridization and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Automated detection of digoxigenin-labelled B19 parvovirus amplicons by a capture hybridization assay

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

Parvovirus B19 in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900104-X

7 January 2021

10.1016/S1386-6532(02)00104-X

Identifiers

DOI

1 reference

6 August 2017

1 reference